NEW See Every New BME Share Your DRIP Buys
Every BME payout in dollars and the exact new shares it buys you — counted automatically, every day.
Track BME »

BlackRock Health Sciences Trust BME | NYSE

Dividends

Company Overview:

Market Cap: $616.35M
Trailing PE: —
FWD PE: —
Payout Ratio (TTM): 259.5%
52-Week Range: $37.51 - $48.30

10 Year BME Performance Metrics:

Total Return (with DRIP): 154.7% (9.80% CAGR)
Total Return (no DRIP): 105.4% (7.46% CAGR)
Share Price: 32.1% (2.83% CAGR)
Yield on Cost (with DRIP): 16.92%
Total Invested: $10,000
Total Value (with DRIP): $25,470
Total Return $ (with DRIP): $15,470
Dividend Increase: 31.0% (2.76% CAGR)
Dividend Yield (FWD): 6.64% ($3.14)
BME 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
BME Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
BME Price CAGR:1Y: 21.01%2Y: 7.08%5Y: -0.45%10Y: 2.82%
BME Dividend Charts
BME - Dividends
BME Dividend CAGR:1Y: 0.04%2Y: 0.00%5Y: 4.17%10Y: 2.72%
BME - Dividend Payout Ratio
BME Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
BME - Dividend to Free Cash Flow Ratio
BME Dividend to FCF Ratio CAGR:1Y: -77.48%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Build Custom Charts
BME - Chart 1
BME - Chart 2
BME - Chart 3

BME Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

Revenue
BME Revenue CAGR:1Y: -76.17%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Earnings Per Share (EPS)
BME EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Net Income
BME Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EBITDA
BME EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Free Cash Flow
BME Free Cash Flow CAGR:1Y: 426.60%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Free Cash Flow / Share
BME Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Operating Income
BME Operating Income CAGR:1Y: -91.44%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Gross Profit
BME Gross Profit CAGR:1Y: -70.91%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Shares Outstanding
BME Shares Outstanding CAGR:1Y: -7.31%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Share Buybacks
BME Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Stock-Based Comp
BME Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Expenses
BME Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Revenue vs Net Income
EPS vs FCF / Share
EPS vs PE Ratio
FCF vs FCF / Share
FCF vs Stock Based Comp

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates
BME Actual Revenue CAGR:1Y: -76.17%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EPS: Actual + Estimates
BME Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
NET INCOME: Actual + Estimates
BME Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EBITDA: Actual + Estimates
BME Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

Net Profit Margin
BME Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Gross Profit Margin
BME Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Price to Earnings
BME Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Price To Sales Ratio
BME Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Return on Capital Employed
BME Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Return on Invested Capital
BME Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

BME Dividends Info:

Annual Dividend: $3.1452
Forward Yield: 6.64%
Ex-Dividend Date: 2026-12-11
Lifetime Dividends / Share: $58.95

Projected Future Returns & Dividends for BME

Based on past 10-year performance, here are BME growth metrics:

Share price CAGR of +2.82%
Dividend CAGR of +2.74%

Using BME CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BME (DRIP)BME - No DRIP
Current Price$47.34$47.34
Start Shares211.24211.24
Start Value$10,000$10,000
  
After 10 years:
Final Share Count408.80211.24
Dividends Payment$0.34$0.34
Annual Dividends$1,686$871
Yield on cost16.86%8.71%
Share Price$62.55$62.55
Total Dividends$10,794$7,527
Final Value$25,569$20,740

Estimated Future Value + Dividends - BME

NOTE: Above numbers are our estimate based on BME's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Is BME's dividend safe, and what is BME worth?

Pro adds BME's Dividend Safety Rating, its DCF fair value and the Trend Signal to this page and opens the 26 blurred charts above.

Show BME's rating and fair value

Company Info

BlackRock Health Sciences Trust (BME) had its IPO on 2005-03-29, and is traded on NYSE stock exchange.

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BME website: https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund


Loading signals…

DCF Model — BME

Value from:
Pay up to today
—
vs current price $47.34
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →